BRIEF-Tetra Bio-Pharma, Intelgenx sign agreement for development, commercialization of Dronabinol XL tablet
April 03, 2017 at 08:14 AM EDT
* Tetra Bio-pharma and Intelgenx announce the signing of a definitive agreement for the development and commercialization of a Dronabinol XL tablet
